Stock listing

Seres Therapeutics, Inc.

Selected listing: A413XF · LSX · EUR · DE

Seres Therapeutics, Inc. (LS Exchange: A413XF), Health Technology. Latest release Sep 1, 2026: Seres Therapeutics to Participate in H.C. Wainwright 28th…

A413XF:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A413XF
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: LS Exchange
Currency: EUR

Latest news from Seres Therapeutics, Inc.

Seres Therapeutics to Participate in H.C. Wainwright 28th Annual Global Investment Conference

September 1, 2026

Seres Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates, Including Further Action to Reduce Ongoing Facilities Costs

August 5, 2026

Seres Therapeutics Announces Early Clinical Data Showing Potential for SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC), a Frequent Adverse Reaction That Forces Many Patients to Halt Cancer Treatment

July 8, 2026

Seres Therapeutics Announces Two Transactions to Strengthen Balance Sheet, Reduce On-Going Lease Costs and Extend Projected Operating Cash Runway Well Into the First Quarter of 2027

June 4, 2026

Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference

May 12, 2026

All Seres Therapeutics, Inc. news →

Events

Replays

Seres Therapeutics, Inc. (MCRB) Q3 2025 Earnings Call
Wed, Nov 05, 2025 · 08:30 AM ET
Watch
Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call
Wed, Aug 06, 2025 · 08:30 AM ET
Watch
Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call
Wed, May 07, 2025 · 08:30 AM ET
Watch

Research Seres Therapeutics, Inc.

Seres Therapeutics, Inc. company profile

View the public company page for Seres Therapeutics, Inc. on 6ix.

Seres Therapeutics, Inc. news

Read company news and market updates connected to Seres Therapeutics, Inc..

Seres Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Seres Therapeutics, Inc..